US2003109819A1PendingUtilityA1
Adhesive preparations
Priority: Dec 15, 1999Filed: Dec 15, 2000Published: Jun 12, 2003
Est. expiryDec 15, 2019(expired)· nominal 20-yr term from priority
A61P 29/00A61K 9/7053A61K 47/32A61K 9/7076A61K 9/70
43
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention provides a patch with less skin stimulation, excellent in long time store stability and heat stability and having favorable tack during use. The patch comprising a styrene-isoprene-styrene block copolymer, polyisobutylene, tackifier, plasticizer and pharmaceutically effective ingredient, in which two or more kinds of polyisobutylene of different average molecular weight are used in combination and the viscosity of the adhesive of the patch is between 1500 and 30,000 poise (at 60° C.) and the tack of the patch is from 5 to 200 g/10 mm.
Claims
exact text as granted — not AI-modified1 . (amended) a patch comprising a styrene-isoprene-styrene block copolymer, polyisobutylene, a tackifier, a plasticizer and pharmaceutically effective ingredients, in which 1-20 % by mass of polyisobutylene having a viscosity average molecular weight of 5,000-15,000 and 0.1-20% by mass of polyisobutylene having a viscosity average molecular weight of 50,000-200,000 are blended, the viscosity of the adhesive of the patch is between 1500 and 30,000 poise (at 60° C.) and the tack of the patch is from 5 to 200 g/10 mm:
2 . A patch as defined in claim 1 , wherein the weight average molecular weight of the styrene-isoprene-styrene block copolymer is from 100,000 to 300,000 and the blending amount thereof is from 10 to 50% by mass.
3 . (deleted)
4 . A patch as defined in claim 1 , wherein the softening point of the tackifier is from 60° C. to 150° C. and the blending amount thereof is from 1 to 50% by mass.
5 . A patch as defined in claim 1 , wherein the viscosity of the plasticzer is from 10 to 100 centistokes (at 40° C.) and the blending amount thereof is from 10 to 70% by mass.
6 . A patch as defined in claim 1 , wherein the blending amount of the pharmaceutically effective ingredient is from 0.001 to 30% by mass.Join the waitlist — get patent alerts
Track US2003109819A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.